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We read with interest the analysis comparing outcomes
in paediatric acute respiratory distress syndrome
(pARDS) among those who required high-frequency os-
cillatory ventilation (HFOV) as ‘rescue therapy’, com-
pared to those who did not [1]. The authors must be
congratulated for using multiple matching techniques to
account for some confounders. We also commend them
for making the code used for analysis public [2]. We
wish to clarify certain aspects of the study that may aid
readers understand the context of the analysis better.
1. The dataset used for genetic matching included at
least 68 ‘matched-pairs’ of severe pARDS. However,
the 68 ‘matches’ were derived from a pool of less
than 39 ‘real’ patients with severe pARDS in the
non-HFOV cohort. While multiple matching with
replacement may improve matching, it would be
helpful to understand how many multiple matches
were made from the smaller pool of non-HFOV pa-
tients and whether statistical adjustments were
made for the duplicates in addition to a pairwise
comparison.
2. The authors reported that the sensitivity analysis
showed consistent findings with the primary
analysis. Curiously, the odds ratios of mortality for
mild, moderate and severe pARDS in the logistic
regression analysis were 1.61, 1.02, and 1.00
respectively. This paradoxical trend may indicate an
interaction between the use of HFOV and presence
of moderate (or) severe pARDS, rather than the risk
of HFOV per se. Was an interaction between the
use of HFOV and severity of pARDS tested and
accounted for in the logistic regression analysis?
3. The intention to match patients in a propensity- or
genetic-matched study is to account for con-
founders present, when an intervention was indi-
cated, between those that received the intervention
compared to those that did not. The use of day 1
OI, rather than the OI immediately prior to the
initiation of HFOV, may have systematically under-
estimated the true severity of pARDS in the HFOV
group, given that HFOV was used as a ‘rescue
mode’ anytime within 7 days. An equivalent assign-
ment of pARDS severity could be done using the
‘highest OI’ within the first 7 days in the non-
HFOV group. Was the use of OI prior to initiation
of HFOV, rather than day 1 OI, considered for
analysis?
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1. In the genetic matching (GM) model, we used
matching with replacement aiming to have a larger
matched cohort [1]. Among the 67 uniquely
matched non-high frequency oscillatory ventilation
(HFOV) patients, majority were matched once [40/
67 (59.7%)]. The remainder were matched twice
[16/67 (23.9%)], thrice [5/67 (7.5%)] and more than
This comment refers to the article available at https://doi.org/10.1186/
s13054-020-2741-x.
* Correspondence: dr.h.krishnan@gmail.com
1PICU, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4
6NH, UK
Full list of author information is available at the end of the article
Kanthimathinathan and Kneyber Critical Care          (2020) 24:116 
https://doi.org/10.1186/s13054-020-2837-3
three times [6/67 (9.0%)]. No adjustments were
made for multiple matched pairs. However, experi-
ments of GM without replacement showed consist-
ent findings with our main analysis [odds ratio (OR)
for mortality 1.9, 95% confidence interval (CI) 1.0
to 4.0; p = 0.09] lending confidence to the results.
2. We performed logistic regression with interaction
term between HFOV use and paediatric acute
respiratory distress syndrome (PARDS) severity and
compared this with the original model without the
interaction term using chi-square test and the
‘ANOVA’ function in R software. There was no im-
provement (p = 0.16) with introducing the inter-
action term, and hence, this was omitted.
We hypothesized that HFOV use is beneficial in
certain patient subgroups. We reported subgroup
analyses (severe and non-severe PARDS) in the sup-
plementary material (Table S3.2). A trend towards
harm was associated with HFOV use in the non-
severe [OR 2.9 (95% CI 1.1 to 8.1); p = 0.06] and
severe [OR 1.6 (95% CI 0.7 to 3.5); p = 0.29] cohort,
but the effect size in severe PARDS seemed lower.
This paradoxical trend was similar to the multivari-
ate analysis. However, this hypothesis may only be
answered with the completion of the PROSPect trial
(NCT03896763).
3. In our main analysis, we used oxygenation index
(OI) calculated on the second day of PARDS, which
has strong correlation to clinical outcomes [3].
However, anticipating the possibility of PARDS
progression in the following days leading up to
HFOV use, we also performed a sensitivity analysis
using daily OI to adjust for time-varying confound-
ing in the first week of PARDS (Tables S7.1 and
S7.2). All three statistical approaches (GM, propen-
sity score matching and marginal structural model-
ling) demonstrate a consistent direction of harmful
effect. This approach is likely more robust than
using a single day’s OI value.
In summary, our findings remain consistent—there is
a signal toward harm in using HFOV in the general co-
hort of PARDS patients, especially in non-severe cases
who otherwise have no other organ involvement. For the
subgroup with severe PARDS, an empirical study is ne-
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